1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Global Biologics and Biosimilars Industry Report 2015

Global Biologics and Biosimilars Industry Report 2015

  • November 2015
  • -
  • QY Research Group
  • -
  • 212 pages

Summary

The Global Biologics and Biosimilars Industry Report 2015 is a professional and in-depth study on the current state of the Biologics and Biosimilars industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biologics and Biosimilars market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Biologics and Biosimilars industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 328 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Biologics and Biosimilars Industry Report 2015
Table of Contents

1 Industry Overview 1
1.1 Definition and Specifications of Biologics and Biosimilars 1
1.1.1 Definition of Biologics and Biosimilars 1
1.1.2 Specifications of Biologics and Biosimilars 2
1.2 Classification of Biologics and Biosimilars 4
1.3 Applications of Biologics and Biosimilars 4
1.4 Industry Chain Structure of Biologics and Biosimilars 5
1.5 Industry Overview and Major Regjions Status of Biologics and Biosimilars 6
1.5.1 Industry Overview of Biologics and Biosimilars 6
1.5.2 Global Major Regions Status of Biologics and Biosimilars 7
1.6 Industry Policy Analysis of Biologics and Biosimilars 7
1.7 Industry News Analysis of Biologics and Biosimilars 8
2 Manufacturing Cost Structure Analysis of Biologics and Biosimilars 10
2.1 Labor Cost Analysis of Biologics and Biosimilars 10
2.2 Other Costs Analysis of Biologics and Biosimilars 14
2.3 Manufacturing Cost Structure Analysis of Biologics and Biosimilars 15
2.4 Manufacturing Process Analysis of Biologics and Biosimilars 15
2.5 Global Gross of Biologics and Biosimilars 2010-2015 17
3 Technical Data and Manufacturing Plants Analysis of Biologics and Biosimilars 18
3.1 Revenue and Commercial Production Date of Global Key Manufacturers in 2014 18
3.2 RandD Status and Technology Source of Global Biologics and Biosimilars Key Manufacturers in 2014 19
4 Production Analysis of Biologics and Biosimilars by Regions, Types, and Applications 20
4.1 Global Production of Biologics and Biosimilars by Regions 2010-2015 20
4.2 Global Production of Biologics and Biosimilars by Type 2010-2015 26
4.3 Global Production of Biologics and Biosimilars by Applications 2010-2015 27
4.4 US Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2010-2015 29
4.5 EU Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2010-2015 30
4.6 Middle East Revenue, Supply, Import, Export and Consumption of Biosimilars 2010-2015 31
4.7 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2010-2015 31
4.8 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2010-2015 32
5 Consumption Volume and Consumption Value Analysis of Biologics and Biosimilars by Regions 34
5.1 Global Consumption Volume of Biologics by Regions 2010-2015 34
5.2 Global Consumption Value of Biosimilars by Regions 2010-2015 37
6 Analysis of Biologics and Biosimilars Production, Supply, Sales and Market Status 2010-2015 41
6.1 Revenue Market Share Analysis of Biologics 2010-2015 41
6.2 Revenue Market Share Analysis of Biosimilars 2010-2015 52
6.3 Sales Overview of Biologics and Biosimilars 2010-2015 60
6.4 Supply, Sales and Gap of Biologics and Biosimilars 2010-2015 61
6.5 Import, Export and Consumption of Biologics and Biosimilars 2010-2015 62
6.6 Cost, Price, Revenue and Gross Margin of Biologics and Biosimilars 2010-2015 62
7 Key Manufacturers Analysis of Biologics and Biosimilars Industry 78
Biologics 78
7.1 Roche 78
7.1.1 Company Profile 78
7.1.2 Product Picture and Specifications 79
7.1.3 Cost, Gross, and Revenue 80
7.1.4 Contact Information 81
7.2 Amgen 81
7.2.1 Company Profile 81
7.2.2 Product Picture 82
7.2.3 Cost, Gross, and Revenue 83
7.2.4 Contact Information 84
7.3 AbbVie 84
7.3.1 Company Profile 84
7.3.2 Product Picture and Specifications 86
7.3.3 Cost, Gross, and Revenue 86
7.3.4 Contact Information 87
7.4 Sanofi-Aventis 88
7.4.1 Sanofi-Aventis Company Profile 88
7.4.2 Product Picture and Specifications 89
7.4.3 Cost, Gross, and Revenue 89
7.4.4 Contact Information 90
7.5 Johnson and Johnson 90
7.5.1 Company Profile 90
7.5.2 Product Picture 92
7.5.3 Cost, Gross, and Revenue 92
7.5.4 Contact Information 94
7.6 Pfizer 94
7.6.1 Company Profile 94
7.6.2 Product Picture 96
7.6.3 Cost, Gross, and Revenue 97
7.6.4 Contact Information 98
7.7 Novo Nordisk 98
7.7.1 Company Profile 98
7.7.2 Product Picture 99
7.7.3 Cost, Gross, and Revenue 100
7.7.4 Contact Information 101
7.8 Eli Lilly 101
7.8.1 Eli Lilly 101
7.8.2 Product Picture 102
7.8.3 Cost, Gross, and Revenue 102
7.8.4 Contact Information 104
7.9 Novartis 104
7.9.1 Novartis Company Profile 104
7.9.2 Product Picture and Specifications 105
7.9.3 Cost, Gross, and Revenue 106
7.9.4 Contact Information 107
7.10 Merck 107
7.10.1 Merck 107
7.10.2 Product Picture and Specifications 109
7.10.3 Cost, Gross, and Revenue 109
7.10.4 Contact Information 110
7.11 3sbio 111
7.11.1 3sbio Company Profile 111
7.11.2 Product Picture 112
7.11.3 Cost, Gross, and Revenue 112
7.11.4 Contact Information 113
7.12 Changchun High Tech 113
7.12.1 Changchun High Tech Company Profile 113
7.12.2 Product Picture 114
7.12.3 Cost, Gross, and Revenue 114
7.12.4 Contact Information 116
7.13 CP Guojian Pharmacy 116
7.13.1 CP Guojian Pharmacy 116
7.13.2 Product Picture 117
7.13.3 Cost, Gross, and Revenue 117
7.13.4 Contact Information 118
7.14 Biotech Pharma 119
7.14.1 Biotech Pharma 119
7.14.2 Product Picture 120
7.14.3 Cost, Gross, and Revenue 120
7.14.4 Contact Information 121
7.15 Gelgen Biopharma 122
7.15.1 Gelgen Biopharma 122
7.15.2 Product Picture 123
7.15.3 Cost, Gross, and Revenue 123
7.15.4 Contact Information 124
7.16 Innovent 125
7.16.1 Innovent 125
7.16.2 Product Picture 126
7.16.3 Cost, Gross, and Revenue 126
7.16.4 Contact Information 127
7.17 Tong Hua Dong Bao Group 128
7.17.1 Company Profile 128
7.17.2 Product Picture 129
7.17.3 Cost, Gross, and Revenue 129
7.17.4 Contact Information 130
7.18 Ganlee 130
7.18.1 Company Profile 130
7.18.2 Product Picture 131
7.18.3 Cost, Gross, and Revenue 131
7.18.4 Contact Information 132
7.19United Laboratories 133
7.19.1 United Laboratories Company Profile 133
7.19.2 Product Picture and Specifications 134
7.19.3 Cost, Gross, and Revenue 134
7.19.4 Contact Information 135
Biosimilar 136
7.1 SANDOZ (NOVARTIS) 136
7.1.1 Company Profile 136
7.1.2 Product Picture and Specifications 137
7.1.3 Cost, Gross, and Revenue 137
7.1.4 Contact Information 138
7.2 Teva Pharmaceutical 139
7.1.1 Company Profile 139
7.1.2 Product Picture and Specifications 140
7.2.3 Cost, Gross, and Revenue 140
7.1.4 Contact Information 141
7.3 Hospira ?Pfizer? 142
7.1.1 Company Profile 142
7.1.2 Product Picture and Specifications 143
7.3.3 Cost, Gross, and Revenue 143
7.1.4 Contact Information 144
7.4 MYLAN 145
7.4.1 Company Profile 145
7.4.2 Product Picture and Specifications 146
7.4.3 Cost, Gross, and Revenue 146
7.4.4 Contact Information 147
7.5 3sbio 148
7.5.1 3sbio Company Profile 148
7.5.2 Product Picture 149
7.5.3 Cost, Gross, and Revenue 149
7.5.4 Contact Information 150
7.6 Changchun High Tech 151
7.6.1 Changchun High Tech Company Profile 151
7.6.2 Product Picture 152
7.6.3 Cost, Gross, and Revenue 152
7.6.4 Contact Information 153
7.7 CP Guojian Pharmacy 153
7.7.1 CP Guojian Pharmacy 153
7.7.2 Product Picture 154
7.7.3 Cost, Gross, and Revenue 154
7.7.4 Contact Information 156
7.8 Biotech Pharma 156
7.8.1 Biotech Pharma 156
7.8.2 Product Picture 157
7.8.3 Cost, Gross, and Revenue 157
7.8.4 Contact Information 158
7.9 Gelgen Biopharma 159
7.9.1 Gelgen Biopharma 159
7.9.2 Product Picture 160
7.9.3 Cost, Gross, and Revenue 160
7.9.4 Contact Information 161
8 Price and Gross Margin Analysis of Biologics and Biosimilars 163
8.1 Analysis of Supply and Consumption 163
8.2 Gross Margin Analysis 164
8.3 Gross Margin Analysis of Different Biologics and Biosimilars Applications 164
9 Marketing Trader or Distributor Analysis of Biologics and Biosimilars 165
9.1 Biologics and Biosimilars Marketing Channels Status 165
9.2 Biologics and Biosimilars Marketing Channels Characteristic 166
9.3 Traders or Distributors of Biologics and Biosimilars with Contact Information 167
9.4 Regional Import, Export and Trade Analysis of Biologics and Biosimilars 168
10 Development Trend of Biologics and Biosimilars Industry 2016-2021 169
10.1 Capacity and Production Overview of Biologics and Biosimilars 2016-2021 169
10.2 Production Market Share Analysis of Biologics and Biosimilars 2016-2021 171
10.3 Sales Overview of Biologics and Biosimilars 2016-2021 174
10.4 Supply, Sales, and Gap of Biologics and Biosimilars 2016-2021 175
10.5 Import, Export and Consumption of Biologics and Biosimilars 2016-2021 176
10.6 Cost, Price, Revenue and Gross Margin of Biologics and Biosimilars 2016-2021 176
11 Industry Chain Suppliers with Contact Information of Biologics and Biosimilars 178
11.1 Manufacturing Equipment Suppliers of Biologicas and Biosimilars with Contact Information 178
11.2 Major Suppliers of Biologicas and Biosimilars with Contact Information 178
11.3 Key Consumers of Biologicas and Biosimilars with Contact Information 179
11.4 Supply Chain Relationship Analysis of Biologics and Biosimilars 180
12 New Project Investment Feasibility Analysis of Biologics and Biosimilars 181
12.1 New Project SWOT Analysis of Biologics and Biosimilars 181
12.2 New Project Investment Feasibility Analysis of Biologics and Biosimilars 182
2.2 Biologics and Biosimilars Project PEST Analysis 182
12.2.1 Political Factors 182
12.2.2 Economic Factors 182
12.2.3 Sociocultural Factors 192
12.2.4 Technological Factors 193
13 Conclusion of the Global Biologics and Biosimilars Industry Report 2015 194



Tables and Figures
Figure Biologics and Biosimilars Product Picture 1
Figure Biologics and Biosimilars Product Picture 2
Table Specifications of Biologics and Biosimilars 2
Table Classification of Biologics and Biosimilars 4
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2015 4
Table Application Fields of Biologics and Biosimilars Products 4
Figure 2014 Global Biologics and Biosimilars Major Applications Sales Share 5
Figure Industry Chain Structure of Biologics and Biosimilars 5
Table Major Suppliers of Biologicas and Biosimilars with Contact Information 7
Table Industry Policy of Biologics and Biosimilars 7
Figure 2014 Global FOB Policy and Regulations 8
Table Industry News List of Biologics and Biosimilars 8
Figure 2014 APAC Overview of Average Monthly Labor Cost 10
Figure 2014 Americas Overview of Average Monthly Labor Cost 11
Figure 2014 EMEA Overview of Average Monthly Labor Cost 11
Figure 2010-2015 USA Quarterly Employment Cost Index (ECI) 12
Figure 2010-2015 EU Quarterly Labor Cost Index 12
Figure 2010-2015 Japan Yearly Manufacturing Cash Earnings and Growth Rate 13
Figure 2010-2014 China Yearly Average Wage of Worker and Growth Rate 13
Table 2014 Global Electricity Price of Resident and Industry (USD/Kw•h) by Country 14
Table Manufacturing Cost Structure Analysis of Biologics and Biosimilars in 2014 15
Figure Production Flow Chart of Mammalian Cell Expression System Producing Line 15
Figure Production Flow Chart of Bacterial cell expression system Producing Line 16
Figure Biologics and Biosimilars Marketing Process 16
Figure Global Gross Analysis of Biologics and Biosimilars 2010-2015 17
Table Revenue (M USD) and Commercial Production Date of Global Biologics and Biosimilars Key Manufacturers in 2014 18
Table RandD Status and Technology Source of Global Biologics and Biosimilars Key Manufacturers in 2014 19
Table Global Production of Biologics by Regions 2010-2015 (M USD) 20
Figure Global Production Market Share of Biologics by Regions in 2010 20
Figure Global Production Market Share of Biologics by Regions in 2011 21
Figure Global Production Market Share of Biologics by Regions in 2012 21
Figure Global Production Market Share of Biologics by Regions in 2013 22
Figure Global Production Market Share of Biologics by Regions in 2014 22
Figure Global Production Market Share of Biologics by Regions in 2015 23
Table Global Production of Biosimilars by Regions 2010-2015 (M USD) 23
Figure Global Production Market Share of Biosimilars by Regions in 2010 23
Figure Global Production Market Share of Biosimilars by Regions in 2011 24
Figure Global Production Market Share of Biosimilars by Regions in 2012 24
Figure Global Production Market Share of Biosimilars by Regions in 2013 25
Figure Global Production Market Share of Biosimilars by Regions in 2014 25
Figure Global Production Market Share of Biosimilars by Regions in 2015 26
Table Global Production of Biologics and Biosimilars by Type 2010-2015 (K Units) 26
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2014 27
Table Global Production of Biologics and Biosimilars by Applications 2010-2015 (M USD) 27
Figure Global Production Market Share of Biologics and Biosimilars by Applications in 2014 28
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of US 2010-2015 29
Table US Supply, Import, Export and Consumption of Biologics 2010-2015 (M USD) 29
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of US 2010-2015 29
Table US Supply, Import, Export and Consumption of Biosimilars 2010-2015 (M USD) 29
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2010-2015 30
Table EU Supply, Import, Export and Consumption of Biologics 2010-2015 (M USD) 30
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2010-2015 30
Table EU Supply, Import, Export and Consumption of Biosimilars 2010-2015 (M USD) 30
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2010-2015 31
Table EU Supply, Import, Export and Consumption of Biosimilars 2010-2015 (M USD) 31
Table Japan Supply, Import, Export and Consumption of Biologics 2010-2015 (M USD) 31
Table Japan Supply, Import, Export and Consumption of Biologics 2010-2015 (M USD) 32
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2010-2015 32
Table China Supply, Import, Export and Consumption of Biologics 2010-2015 (M USD) 32
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2010-2015 32
Table China Supply, Import, Export and Consumption of Biosimilars 2010-2015 (M USD) 33
Table Global Consumption Volume of Biologics by Regions 2010-2015 (M USD) 34
Figure Global Consumption Volume of Biologics by Regions in 2010 (M USD) 34
Figure Global Consumption Volume of Biologics by Regions in 2011 (M USD) 35
Figure Global Consumption Volume of Biologics by Regions in 2012 (M USD) 35
Figure Global Consumption Volume of Biologics by Regions in 2013 (M USD) 36
Figure Global Consumption Volume of Biologics by Regions in 2014 (M USD) 36
Figure Global Consumption Volume of Biologics by Regions in 2015 (M USD) 37
Table Global Consumption Value of Biosimilars by Regions 2010-2015 (M USD) 37
Figure Global Consumption Value of Biosimilars by Regions in 2010 (M USD) 38
Figure Global Consumption Value of Biosimilars by Regions in 2011 (M USD) 38
Figure Global Consumption Value of Biosimilars by Regions in 2012 (M USD) 39
Figure Global Consumption Value of Biosimilars by Regions in 2013 (M USD) 39
Figure Global Consumption Value of Biosimilars by Regions in 2014 (M USD) 40
Figure Global Consumption Value and Biosimilars by Regions in 2015 (M USD) 40
Table Global and Major Manufacturers Revenue of Biologics 2010-2015 (M USD) 41
Table Global and Major Manufacturers Revenue Market Share of Biologics 2010-2015 (M USD) 42
Figure Global Production Market Share of Major Biologics Manufacturers in 2010 43
Figure Global Production Market Share of Major Biologics Manufacturers in 2011 44
Figure Global Production Market Share of Major Biologics Manufacturers in 2012 45
Figure Global Production Market Share of Major Biologics Manufacturers in 2013 46
Figure Global Production Market Share of Major Biologics Manufacturers in 2014 47
Figure Global Production Market Share of Major Biologics Manufacturers in 2015 48
Table China Major Manufacturers Revenue of Major Biologics Manufacturers in 2010-2015 48
Table China Major Manufacturers Revenue Market Share of Major Biologics Manufacturers in 2010-2015 49
Figure China Revenue Market Share of Major Biologics Manufacturers in 2010 49
Figure China Revenue Market Share of Major Biologics Manufacturers in 2011 50
Figure China Revenue Market Share of Major Biologics Manufacturers in 2012 50
Figure China Production Market Share of Major Biologics Manufacturers in 2013 51
Figure China Production Market Share of Major Biologics Manufacturers in 2014 51
Figure China Production Market Share of Major Biologics Manufacturers in 2015 52
Table Global and Major Manufacturers Revenue of Biosimilars 2010-2015 (M USD) 52
Table Global and Major Manufacturers Revenue Market Share of Biosimilars 2010-2015 53
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2010 53
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2011 54
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2012 54
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2013 55
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2014 55
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2015 56
Table China Major Manufacturers Revenue of Major Biosimilars Manufacturers in 2010-2015 56
Table China Major Manufacturers Revenue Market Share of Major Biosimilars Manufacturers in 2010-2015 56
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2010 57
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2011 57
Figure China Production Market Share of Major Biosimilars Manufacturers in 2012 58
Figure China Production Market Share of Major Biosimilars Manufacturers in 2013 58
Figure China Production Market Share of Major Biosimilars Manufacturers in 2014 59
Figure China Production Market Share of Major Biosimilars Manufacturers in 2015 59
Figure Global Sales (M USD) and Growth Rate of Biologics and Biosimilars 2010-2015 60
Figure China Sales (M USD) and Growth Rate of Biologics and Biosimilars 2010-2015 61
Table Global Supply, Sales and Gap of Biologics 2010-2015 (M USD) 61
Table Global Supply, Sales and Gap of Biosimilars 2010-2015 (M USD) 61
Table China Supply, Sales and Gap of Biologics 2010-2015 (M USD) 61
Table China Supply, Sales and Gap of Biosimilars 2010-2015 (M USD) 62
Table China Import, Export and Consumption of Biologics 2010-2015 (M USD) 62
Table China Import, Export and Consumption of Biosimilars 2010-2015 (M USD) 62
Table Gross Margin of Global Biologics and Biosimilars Major Manufacturers 2010-2015 62
Figure Gross Margin of Global Biologics and Biosimilars Major Manufacturers in 2014 64
Table Global and Major Manufacturers Revenue of Biologics 2010-2015 (M USD) 64
Table Global and Major Manufacturers Revenue Market Share of Biologics 2010-2015 (M USD) 65
Figure Global Production Market Share of Major Biologics Manufacturers in 2010 66
Figure Global Production Market Share of Major Biologics Manufacturers in 2011 67
Figure Global Production Market Share of Major Biologics and Biosimilars Manufacturers in 2012 68
Figure Global Production Market Share of Major Biologics Manufacturers in 2013 69
Figure Global Production Market Share of Major Biologics Manufacturers in 2014 70
Figure Global Production Market Share of Major Biologics Manufacturers in 2015 71
Table China Major Manufacturers Revenue of Major Biosimilars Manufacturers in 2010-2015 71
Table China Major Manufacturers Revenue Market Share of Major Biosimilars Manufacturers in 2010-2015 72
Table Global and Major Manufacturers Revenue of Biosimilars 2010-2015 (M USD) 72
Table Global and Major Manufacturers Revenue Market Share of Biosimilars 2010-2015 (M USD) 72
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2010 73
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2011 73
Figure Global Production Market Share of Major Biosimilars and Biosimilars Manufacturers in 2012 74
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2013 74
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2014 75
Figure Global Production Market Share of Major Biosimilars Manufacturers in 2015 75
Table China Major Manufacturers Revenue of Major Biosimilars Manufacturers in 2010-2015 75
Table China Major Manufacturers Revenue Market Share of Major Biosimilars Manufacturers in 2010-2015 76
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biologics 2010-2015 76
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biologics 2010-2015 76
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biosimilars 2010-2015 76
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biosimilars 2010-2015 77
Table Roche Company Profile 78
Figure Biologics and Biosimilars Picture of Roche 79
Table Biologics and Biosimilars Specifications of Roche 79
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Roche 2010-2015 80
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Roche 2010-2015 80
Figure Roche Biologics and Biosimilars Revenue (M USD) and Global Market Share of 2010-2015 81
Table Amgen Company Profile 81
Figure Neulasta of Amgen 82
Figure Neupogen of Amgen 83
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Amgen 2010-2015 83
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Amgen 2010-2015 83
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Amgen 2010-2015 84
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of AbbVie 2010-2015 86
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of AbbVie 2010-2015 87
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of AbbVie 2010-2015 87
Table Sanofi-Aventis Company Profile with Contact Information, Plant Location, Capacity, Revenue, etc. 88
Figure Insulin of Sanofi-Aventis 89
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sanofi-Aventis 2010-2015 89
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Sanofi-Aventis 2010-2015 89
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Sanofi-Aventis 2010-2015 90
Table Johnson and Johnson Company Profile with Contact Information, Plant Location, Capacity, Revenue. 90
Table Epoetin alfa of Johnson and Johnson 92
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Johnson and Johnson 2010-2015 92
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Johnson and Johnson 2010-2015 93
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Johnson and Johnson 2010-2015 93
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Pfizer 2010-2015 97
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Pfizer 2010-2015 97
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share Pfizer of 2010-2015 98
Table Novo Nordisk Company Profile with Contact Information, Plant Location, Capacity, Revenue 98
Figure Insulin of Novo Nordisk 99
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Novo Nordisk 2010-2015 100
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Novo Nordisk 2010-2015 100
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Novo Nordisk 2010-2015 101
Table Eli Lilly Company Profile with Contact Information, Plant Location, Capacity, Revenue 101
Figure Insulin of Eli Lilly 102
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Eli Lilly 2010-2015 102
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Eli Lilly 2010-2015 103
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Eli Lilly 2010-2015 103
Table Novartis Company Profile with Contact Information, Plant Location, Capacity, Revenue 104
Figure of atumumab of Novartis 105
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Novartis 2010-2015 106
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Novartis 2010-2015 106
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Novartis 2010-2015 107
Table Merck Company Profile with Contact Information, Plant Location, Capacity, Revenue 107
Figure Insulin of Merck 109
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Merck 2010-2015 109
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Merck 2010-2015 110
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Merck 2010-2015 110
Table 3sbio Company Profile with Contact Information, Plant Location, Capacity, Revenue 111
Figure Biologicas and Biosimilars Picture of 3sbio 112
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of 3sbio 2010-2015 112
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of 3sbio 2010-2015 112
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of 3sbio 2010-2015 113
Table Changchun High Tech Company Profile with Contact Information, Plant Location, Capacity, Revenue. 113
Figure Biologicas and Biosimilars Picture of Changchun High and New Technology Industry 114
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Changchun High Tech 2010-2015 114
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Changchun High Tech 2010-2015 115
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Changchun High Tech 2010-2015 115
Table CP Guojian Pharmacy Company Profile with Contact Information, Plant Location, Capacity, Revenue 116
Figure Biologicas and Biosimilars Picture of CP Guojian 117
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of CP Guojian 2010-2015 117
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of CP Guojian 2010-2015 118
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of CP Guojian 2010-2015 118
Table Biotech Pharma Company Profile with Contact Information, Plant Location, Capacity, Revenue 119
Figure Biologicas and Biosimilars Picture of Biotech Pharma 120
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Biotech Pharma 2010-2015 120
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Biotech Pharma 2010-2015 121
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Biotech Pharma 2010-2015 121
Table Gelgen Biopharma Company Profile with Contact Information, Plant Location, Capacity, Revenue 122
Figure Biologicas and Biosimilars Picture of Gelgen Biopharma 123
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2010-2015 123
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Gelgen Biopharma 2010-2015 124
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Gelgen Biopharma 2010-2015 124
Table Innovent Company Profile with Contact Information, Plant Location, Capacity, Revenue, etc. 125
Figure Biologicas and Biosimilars Picture of Innovent 126
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Innovent 2010-2015 126
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Innovent 2010-2015 127
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Innovent 2010-2015 127
Table Tong Hua Dong Bao Group Company Profile with Contact Information, Plant Location, Capacity, Revenue 128
Figure Insulin Picture of Tong Hua Dong Bao Group 129
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Tong Hua Dong Bao Group 2010-2015 129
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Tong Hua Dong Bao Group 2010-2015 129
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Tong Hua Dong Bao Group 2010-2015 130
Table Ganlee Company Profile with Contact Information, Plant Location, Capacity, Revenue 130
Table Insulin Picture of Ganlee 131
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Ganlee 2010-2015 131
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Ganlee 2010-2015 132
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Ganlee 2010-2015 132
Table United Laboratories Company Profile with Contact Information, Plant Location, Capacity, Revenue 133
Figure Insulin Picture of United Laboratories 134
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of United Laboratories 2010-2015 134
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of United Laboratories 2010-2015 135
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of United Laboratories 2010-2015 135
Table Roche Company Profile 136
Figure Biologics and Biosimilars Picture of SANDOZ 137
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of SANDOZ 2010-2015 137
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of SANDOZ 2010-2015 138
Figure Roche Biologics and Biosimilars Revenue (M USD) and Global Market Share of 2010-2015 138
Table Teva Company Profile 139
Figure Biologics and Biosimilars Picture of Teva 140
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Teva 2010-2015 140
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Teva 2010-2015 141
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Teva 2010-2015 141
Table Hospira Company Profile 142
Figure Biologics and Biosimilars Picture of Hospira 143
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Hospira 2010-2015 143
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Hospira 2010-2015 144
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Hospira 2010-2015 144
Table Roche Company Profile 145
Figure Biologics and Biosimilars Picture of MYLAN 146
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of MYLAN 2010-2015 146
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of MYLAN 2010-2015 147
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of MYLAN 2010-2015 147
Table 3sbio Company Profile with Contact Information, Plant Location, Capacity, Revenue 148
Figure Biologicas and Biosimilars Picture of 3sbio 149
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of 3sbio 2010-2015 149
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of 3sbio 2010-2015 150
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of 3sbio 2010-2015 150
Table Changchun High Tech Company Profile with Contact Information, Plant Location, Capacity, Revenue. 151
Figure Biologicas and Biosimilars Picture of Changchun High and New Technology Industry 152
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Changchun High Tech 2010-2015 152
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Changchun High Tech 2010-2015 152
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Changchun High Tech 2010-2015 153
Table CP Guojian Pharmacy Company Profile with Contact Information, Plant Location, Capacity, Revenue 153
Figure Biologicas and Biosimilars Picture of CP Guojian Pharmacy 154
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of CP Guojian Pharmacy 2010-2015 154
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of CP Guojian Pharmacy 2010-2015 155
Figure CP Guojian Pharmacy Biologics and Biosimilars Revenue (M USD) and Global Market Share of 2010-2015 155
Table Biotech Pharma Company Profile with Contact Information, Plant Location, Capacity, Revenue, etc. 156
Figure Biologicas and Biosimilars Picture of Biotech Pharma 157
Table Biologics and Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Biotech Pharma 2010-2015 157
Figure Biologics and Biosimilars Revenue (M USD) and Growth Rate of Biotech Pharma 2010-2015 158
Figure Biologics and Biosimilars Revenue (M USD) and Global Market Share of Biotech Pharma 2010-2015 158
Table Gelgen Biopharma Company Profile with Contact Information, Plant

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...


Download Unlimited Documents from Trusted Public Sources

Biosimilar Industry in Europe

  • November 2016
    42 pages
  • Biosimilar  

  • Europe  

View report >

Pathology Statistics in Canada

  • October 2016
    2 pages
  • Biosimilar  

  • Canada  

    North America  

View report >

Global Breast Cancer Statistics

  • October 2016
    2 pages
  • Breast Cancer  

    Biosimilar  

  • Europe  

    World  

    Hungary  

View report >

Bioprocessing Industry

3 months ago

Biosimilar Statistics

3 months ago

Biosimilar Statistics

3 months ago

Related Market Segments :

Biosimilar

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.